BRD4 modulates antimicrobial defense via non-canonical NRF2 activation in macrophages to confer protection against sepsis
PLOS Pathogens · 30.04.2026 · 22 (4) · e1014192
DOI: 10.1371/journal.ppat.1014192 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 30.04.2026. Verfasst von Jinfeng Hu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Cognitive Function and Diseases, Institute for Basic Medical Sciences, School of Basic Medical Sciences, Fujian Medical Univ…. Hauptthemen laut MEDLINE: Sepsis, NF-E2-Related Factor 2, Transcription Factors, Macrophages. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds for Innovation in Science and Technology, Fujian Province, Natural Science Foundation of Fujian Province.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening condition characterized by dysregulated immune responses and high mortality, driven by persistent pathogens and compromised antimicrobial defenses. We identify BRD4, an epigenetic regulator, as a crucial modulator of macrophage antimicrobial function and survival in sepsis. Sepsis significantly reduces BRD4 expression in monocytes/macrophages in both human patients and murine models, with decreased BRD4 levels correlating with disease severity. Myeloid-specific deletion of Brd4 exacerbates mortality by impairing macrophage phagocytosis and bactericidal activity. BRD4 interacts with NRF2, disrupting the NRF2-KEAP1 complex, which enhances NRF2 stability and nuclear translocation, leading to the upregulation of scavenger receptors essential for bacterial clearance. Notably, restoration or activation of NRF2 rescues the macrophage functional defects induced by Brd4 deficiency both in vitro and in vivo , highlighting the therapeutic potential of this pathway. Our findings reveal that BRD4 downregulation in human sepsis predicts disease severity, presenting BRD4 as both a biomarker and a therapeutic target. The BRD4-NRF2 axis offers a novel approach to restoring host defense and improving sepsis treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Cognitive Function and Diseases, Institute for Basic Medical Sciences, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
- Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
- Department of Emergency Medicine, Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- School of Medicine, Shaoxing University, Shaoxing, China.
- Longquan Industrial Innovation Research Institute, Lishui, China.
- Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou China.
ORCID-Profile: Xiangming Hu
Förderung
- National Natural Science Foundation of China
- Joint Funds for Innovation in Science and Technology, Fujian Province
- Natural Science Foundation of Fujian Province
- Fujian Medical University
Zitieren
APA
Hu, J., Gao, X., Li, G., He, X., Ke, Y., Zhang, Z., Pang, D., Lin, Z., Xie, C., Chen, X., Jiang, M., Zheng, S., Yu, S., Lin, M., Pan, D., Shen, X., & Hu, X. (2026). BRD4 modulates antimicrobial defense via non-canonical NRF2 activation in macrophages to confer protection against sepsis. PLOS Pathogens, 22(4), e1014192. https://doi.org/10.1371/journal.ppat.1014192
Vancouver
Hu J, Gao X, Li G, He X, Ke Y, Zhang Z, et al. BRD4 modulates antimicrobial defense via non-canonical NRF2 activation in macrophages to confer protection against sepsis. PLOS Pathogens. 2026;22(4):e1014192. doi:10.1371/journal.ppat.1014192
BibTeX
@article{Hu2026,
author = {Hu, Jinfeng and Gao, Xuming and Li, Guo and He, Xiaoxin and Ke, Yanting and Zhang, Zhongheng and Pang, Duozhi and Lin, Zhen and Xie, Cailian and Chen, Xiaoting and Jiang, Minting and Zheng, Shuping and Yu, Suhong and Lin, Mingrui and Pan, Dun and Shen, Xiaopei and Hu, Xiangming},
title = {BRD4 modulates antimicrobial defense via non-canonical NRF2 activation in macrophages to confer protection against sepsis},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {4},
pages = {e1014192},
doi = {10.1371/journal.ppat.1014192}
}
EUVIMED